Answers are grounded in this paper and cite their sources.
Aims: This study investigates the antimicrobial resistance and phenotypic detection of extended-spectrum beta-lactamase in Escherichia coli from children with cases of diarrhea in Nasarawa-south, Nasarawa State, Nigeria. Place and Duration of Study: Nasarawa South, Nigeria, in 2023. Methodology: A total of 251 non-duplicate E. coli isolates were collected from Dalhatu Araf Specialist Hospital Lafia (DASHL), General Hospitals Awe (GHA), General Hospital Doma (GHD), General Hospital Obi (GHO) and General Hospital Keana (GHK); and confirmed using standard microbiological methods. Antimicrobial susceptibility testing and phenotypic detection of ESBL production in the isolates were carried out using disc diffusion methods. Results: The isolates were highly resistant (74.0-100.0%) to ampicillin, amoxicillin/clavulanic acid and sulfamethoxazole/trimethoprim, ceftriaxone and streptomycin in all the selected hospitals, but less resistance (0-7.8%) to Cefotaxime and Ceftazidime. All the antibiotic resistance isolates were multiple antibiotic resistance (MAR) with MAR indices above 0.2; and more than 90.0% in all hospitals were multidrug resistance (MDR) isolates. The occurrence of ESBL producing isolates was highest in DASHL (7.8%), GHK and GHD (2.0%) but none of the isolates from GHA were ESBL producers. Conclusion: Extended-spectrum third generation cephalosporins, cefotaxime and ceftazidime were very effective against the isolates, even though most of the isolates were multidrug resistant. The molecular diversity of the ESBL-producing isolates is being investigated.
No takes yet. Share an insight, caveat, or question.
AT et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: